BACKGROUND The purpose of this study was to report the efficacy of routine follow-up after head and neck cancer treatment. METHOD Data for 520 patients with head and neck cancer registered with between 2002 and 2008 were reviewed retrospectively. RESULTS The mean ± SD follow-up period taken into account was 34.7 ± 22.8 months. The pickup rate for recurrence using our follow-up protocol in t...

Rapid advances in the ability to produce nanoparticles of uniform size, shape, and composition have started a revolution in the sciences. Nano-sized structures herald innovative technology with a wide range of potential therapeutic and diagnostic applications. More than 1000 nanostructures have been reported, many with potential medical applications, such as metallic-, dielectric-, magnetic-, l...

Multidisciplinary teams of clinicians manage patients with head and neck cancer in the UK. The lead clinician for any particular patient is likely to be either a surgeon or an oncologist but they rely on the skills of many health care professionals for both diagnostic and therapeutic purposes. This paper outlines the role of the surgeon within the head and neck cancer team, their key tasks and ...

We read with great interest the recent article on Public Awareness of Head and Neck Cancer by O’Connor Papanikolaou & Keogh (2010) 1 . Firstly, we would like to commend the authors for highlighting this important issue. The low public awareness of HNC and its associated risk factors continues to hamper efforts to reduce the morbidity and mortality of this disease both nationally and internati...

Background. Our objective was to develop and examine the psychometric properties of the Satisfaction With Cancer Information Profile (SCIP), a new measure designed to assess the extent to which patients with head and neck cancer (HNC) are satisfied with information received about their treat-

Head and neck cancers pose an especially serious problem in developing countries due to late presentation requiring complex surgical intervention. These countries are faced with many challenges, ranging from insufficient health care staff to problems with peri-operative requirements, diagnostic facilities, chemoradiation services and research funding.These challenges can be addressed through th...

OBJECTIVE Translate to brazilian portuguese, culturally adapt and test the rating and classification scales of cervicofacial lymphedema of the MD Anderson Cancer Center Head and Neck Lymphedema Protocol (MDACC HNL) in patients undergoing treatment for head and neck cancer. METHODS The process followed international guidelines and translation stages by two head and neck surgeons, and back tran...

Head and neck cancer (HNC) is the sixth most common malignancy worldwide. Despite recent advancements in surgical, chemotherapy, and radiation treatments, HNC remains a highly morbid and fatal disease. Unlike many other cancers, local control rather than systemic control is important for HNC survival. Therefore, novel local therapy in addition to systemic therapy is urgently needed. Oncolytic v...

Pneumatosis intestinalis is a rare but known potential complication of treatment with cetuximab. Here we present two cases of pneumatosis intestinalis occurring in patients who were receiving cetuximab as treatment for advanced head and neck cancer. In both cases, cetuximab was discontinued after discovery of the pneumatosis intestinalis.

Introduction: Critical organs and structures may receive significant amounts of irradiation even if they are not the target of radiotherapy or located outside the treatment field. Although the sensitive thyroid gland and lens are not directly the targets of treatment, they can be affected by irradiation during the treatment of tumours in head and neck region. The purpose of thi...